ArticleActa pharmaceutica (Zagreb, Croatia)2022
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents
Qing Su et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it